IP Library Granted Patent US 7,964,361
Granted Patent B2
US 7,964,361 · App. 11/798,549 · Granted Jun 21, 2011

Rigidized trimethine cyanine dyes

Assignee: Carnegie Mellon University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,964,361
App. No.
11/798,549
Granted
Jun 21, 2011
Kind
B2
Abstract

Disclosed are analogues of trimethine cyanine dyes, which are useful for importing fluorescent properties to target materials by covalent and non-covalent association.

Claims (86)

1. A method for covalently labelling a target material comprising the steps of reacting together:

i) a target material having at least one functional group selected from the group consisting of amino, hydroxyl, phosphoryl, carbonyl and sulphydryl groups; or having at least one reactive group that can covalently bond with said at least one functional group; and,

ii) an amount of the compound (I) of formula:

substituted by groups R 2 -R 9 , wherein groups R 6 , R 7 , R 8 and R 9 are attached to the atoms of the Z a and Z b ring structures;

wherein,

R 2 to R 9 are the same or different and are —R 10 or -L-R 10 where R 10 is selected from hydrogen halogen amide C 1 -C 6 alkoxy, nitro, cyano, aryl, heteroaryl, sulphonate quaternary ammonium, guanidinium, hydroxyl, phosphate, phosphonate, optionally substituted amino, azido, sulphydryl, carboxyl, carbonyl and reactive groups selected from succinimidyl ester, isothiocyanate, anhydride, haloacetamide, maleimide, sulphonyl halide, phosphoramidite, acid halide, alkylimidate, hydrazide and carbodiimide, and L is selected from the group consisting of a straight or branched C 1-20 alkyl chain a C 2-20 monoether or polyether and a C 2-20 atom chain containing to four secondary amide linkages;

wherein,

at least one of groups R 2 to R 9 is a functional group selected from the group consisting of amino, hydroxyl, phosphoryl, carbonyl and sulphydryl; or wherein at least one of groups R 2 to R 9 is a reactive group selected from succinimidyl ester, isothiocyanate, anhydride, haloacetamide, maleimide, sulphonyl halide, phosphoramidite, acid halide, alkylimidate, hydrazide and carbodiimide that can covalently bond with said at least one functional group, or at least one of the groups R 2 to R 9 is hydrogen, methyl, phenyl or naphthyl;

R 1 is selected from hydrogen, aryl, heteroaryl, cyano, nitro, aldehyde, halogen, hydroxy, amino, quaternary amino, acetal, ketal, phosphoryl, sulphydryl, and alkyl groups optionally substituted by amino, C 1 -C 4 alkyl-substituted amino, quaternary amino, aldehyde, ketone, acetal, ketal, halo, cyano, aryl, heteroaryl, hydroxyl, sulphonate, sulphate, carboxylate, amide and nitro;

A is selected from O, S and NR 11 where R 11 is the substituted amino radical:

where R′ is selected from hydrogen, a C 1-4 alkyl and aryl and R″ is selected from C 1-18 alkyl, aryl, heteroaryl, an acyl radical having from 2-7 carbon atoms, and a thiocarbamoyl radical;

X and Y may be the same or different and are selected from bis-C 1 -C 4 alkyl and C 4 -C 5 spiro alkyl substituted carbon, oxygen, sulphur, selenium, and N—W wherein N is nitrogen and W is selected from hydrogen, a group —(CH 2 ) n R 12 where n is an integer from 1 to 26 and R 12 is selected from hydrogen, amino, aldehyde, acetal, ketal, halo, cyano, aryl, heteroaryl, hydroxyl, sulphonate, sulphate, carboxylate, substituted amino, quaternary amino, nitro, primary amide and substituted amide;

Z a and Z b each represent the atoms necessary to complete one, or two fused aromatic rings each ring having six carbon atoms;

provided that

when X and Y are other than carbon, at least one of R 2 -R 9 represents -L-R 10 or R 10 wherein R 10 is said reactive group and L is selected from the group consisting of a straight or branched C 1-20 alkyl chain, a C 2-20 monoether or polyether and a C 2-20 atom chain containing up to four secondary amide linkages, or

when X and Y are different and are selected from O and Se, at least one of R 1 -R 9 is other than hydrogen, methyl, phenyl or naphthyl;

wherein said reacting is performed for a period of time sufficient to permit said at least one functional or reactive group of said fluorescent compound to covalently bond to said at least one reactive or functional group of said target material.

2. A method for covalently labelling a target material comprising the steps of reacting together:

i) a target material having at least one functional group selected from the group consisting of amino, hydroxyl, phosphoryl, carbonyl and sulphydryl groups; or having at least one reactive group that can covalently bond with said at least one functional group; and,

ii) an amount of the compound (I) of formula:

(I)

substituted by groups R 2 -R 9 , wherein groups R 6 , R 7 , R 8 and R 9 are attached to the atoms of the Z a and Z b ring structures;

wherein,

R 2 to R 9 are the same or different and are —R 10 or -L-R 10 where R 10 is selected from hydrogen, halogen, amide, C 1 -C 6 alkoxy, nitro, cyano, aryl, heteroaryl, sulphonate, quaternary ammonium, guanidinium, hydroxyl, phosphate, phosphonate, optionally substituted amino, azido, sulphydryl, carboxyl, carbonyl and reactive groups selected from succinimidyl ester, isothiocyanate, anhydride, haloacetamide, maleimide, sulphonyl halide, phosphoramidite, acid halide, alkylimidate, hydrazide and carbodiimide, and L is selected from the group consisting of a straight or branched C 1-20 alkyl chain, a C 2-20 monoether or polyether and a C 2-20 atom chain containing up to four secondary amide linkages;

R 1 is selected from hydrogen, aryl, heteroaryl, cyano, nitro, aldehyde, halogen, hydroxy, amino, quaternary amino, acetal, ketal, phosphoryl, sulphydryl, and alkyl groups optionally substituted by amino, C 1 -C 4 alkyl-substituted amino, quaternary amino, aldehyde, ketone, acetal, ketal, halo, cyano, aryl, heteroaryl, hydroxyl, sulphonate, sulphate, carboxylate, amide and nitro;

A is selected from O, S and NR 11 where R 11 is the substituted amino radical:

where R′ is selected from hydrogen, a C 1-4 alkyl and aryl and R″ is selected from C 1-18 alkyl, aryl, heteroaryl, an acyl radical having from 2-7 carbon atoms, and a thiocarbamoyl radical;

X and Y may be the same or different and are selected from bis-C 1 -C 4 alkyl and C 4 -C 5 spiro alkyl substituted carbon, oxygen, sulphur, selenium, and N—W wherein N is nitrogen and W is selected from hydrogen, a group —(CH 2 ) n R 12 where n is an integer from 1 to 26 and R 12 is selected from hydrogen, amino, aldehyde, acetal, ketal, halo, cyano, aryl, heteroaryl, hydroxyl, sulphonate, sulphate, carboxylate, substituted amino, quaternary amino, nitro, primary amide and substituted amide;

Z a and Z b each represent the atoms necessary to complete one, or two fused aromatic rings each ring having six carbon atoms;

provided that

when X and Y are different and are selected from O and Se, at least one of R 1 -R 9 is other than hydrogen, methyl, phenyl or naphthyl;

wherein said reacting is performed for a period of time sufficient to permit said at least one reactive group of said fluorescent compound to covalently bond to said at least one reactive or functional group of said target material.

3. The method of claim 1 wherein R 1 is selected from hydrogen, aryl, heteroaryl, cyano, halogen, alkyl groups of twenty-six carbon atoms or less and —(CH 2 ) n Q where 1<n<26 and Q is selected from amino, aldehyde, hydroxyl and groups reactive with amino, hydroxyl, aldehyde, phosphoryl, or sulphydryl groups and R 2 , R 3 , R 4 and R 5 are hydrogen.

4. The method of claim 1 wherein compound (I) is selected from:

i) 6,7,9,10-Tetrahydro-2,14-carboxymethyl-16,16,18,18-tetramethyl-7aH, 8aH -bisindolinium[3,2-a;3′2′-a′]pyrano[3,2-c;5,6-c′]dipyridin-5-ium (Compound I);

ii) 8,9,11,12-Tetrahydro-3,17-disulphonato-20,20,22,22-tetramethyl-9aH,10aH-bisbenz[e]indolinium[3,2-a,3′2′-a]pyrano[3,2-c;5,6-c′]dipyridin-7-ium (Compound II);

iii) 6,7,9,10-Tetrahydro-2-carboxymethyl-14-sulphonato-16,16,18,18-tetramethyl-7aH,8aH-bisindolinium[3,2-a,3′2′-a]pyrano[3,2-c;5,6-c′]dipyridin-5-ium (Compound III);

iv) 6,7,9,10-Tetrahydro-2-carboxymethyl-14-sulphonato-16,16,18,18-tetramethyl-7aH,8aH-bisindolinium[3,2-a,3′2′-a]pyrano[3,2-c;5,6-c′]dipyridin-5-ium, glycinamide (Compound IV);

v) 6,7,9,10-Tetrahydro-2-carboxymethyl-14-sulphonato-16,16,18,18-tetramethyl-7aH,8aH-bisindolinium[3,2-a,3′2′-a]pyrano[3,2-c;5,6-c′]dipyridin-5-ium, N-(2-aminoethylcarboxamide) (Compound V);

vi) 6,7,9,10-Tetrahydro-2-(N-formyl)aminomethyl-14-sulphonato-16,16,18,18-tetramethyl-7aH,8aH-bisindolinium[3,2-a,3′2′-a]pyrano[3,2-c;5,6-c′]dipyridin-5-ium (Compound VI);

vii) 6,7,9,10-Tetrahydro-2-hydroxyethyl-16,16,18,18-tetramethyl-7aH,8aH-bisindolinium[3,2-a,3′2′-a]pyrano[3,2-c;5,6-c′]dipyridin-5-ium (Compound VII);

viii) 6,7,8,10-Tetrahydro-14-carboxymethyl-16,16-dimethyl-7a-8a-benzothiazolenine-indolenine-[3,2-a]-benzthiazolyl[3′2′-a]-pyrano[3,2-c;5,6-c′]dipyridin-5-ium (Compound VIII);

ix) 6,7,8,8a,9,10-Hexahydro-2,14-disulphonato-8-(4-carboxy-anilino)-16,16,18,18-tetramethyl-7aH-bis-indolinium[3,2-a;3′2′-a′]pyrido[3,2-c;5,6-c′]dipyridin-5-ium (Compound IX);

x) 6,7,9,10-Tetrahydro-14-carboxymethyl-16,16-dimethyl-7a-8a-quinolino-indolenium-[3,2-a,3′2′-a]-pyrano[3,2-c;5,6-c′]dipyridin-5-ium (Compound X).

5. The method of claim 1 wherein the compound (I) is 6,7,9,10-Tetrahydro-2-carboxymethyl-14-sulphonato-16,16,18,18-tetramethyl-7aH,8aH-bisindolinium[3,2-a,3′2′-a]pyrano[3,2-c;5,6-c′]dipyridin-5-ium or its esters.

6. The method of claim 5 wherein the ester is a N-hydroxysuccinimidyl ester.

7. A method according to claim 1 , wherein said target material is selected from antibody, lipid, protein, peptide, carbohydrate, nucleotides which contain or are derivatized to contain one or more of an amino, sulphydryl, carbonyl, hydroxyl and carboxyl, phosphate and thiophosphate groups, and oxy or deoxy polynucleic acids which contain or are derivatized to contain one or more of an amino, sulphydryl, carbonyl, hydroxyl and carboxyl, phosphate and thiophosphate groups, microbial materials, drugs, toxins, particles, plastics or glass surfaces and polymers.

8. A target material selected from antibody, lipid, protein, peptide, carbohydrate, nucleotides which contain or are derivatized to contain one or more of an amino, sulphydryl, carbonyl, hydroxyl and carboxyl, phosphate and thiophosphate groups, and oxy or deoxy polynucleic acids which contain or are derivatized to contain one or more of an amino, sulphydryl, carbonyl, hydroxyl and carboxyl, phosphate and thiophosphate groups, microbial materials, drugs, toxins, particles, plastics or glass surfaces and polymers herein said target material is covalently labelled with a compound (I) of formula:

substituted by groups R 2 -R 9 , wherein groups R 6 , R 7 , R 8 and R 9 are attached to the atoms of the Z a and Z b ring structures;

wherein,

R 2 to R 9 are the same or different and are —R 10 or -L-R 10 where R 1 is selected from hydrogen halogen amide C 1 -C 6 alkoxy, nitro, cyano, aryl, heteroaryl, sulphonate quaternary ammonium, guanidinium, hydroxyl, phosphate, phosphonate, optionally substituted amino, azido, sulphydryl, carboxyl, carbonyl and reactive groups selected from succinimidyl ester, isothiocyanate, anhydride, haloacetamide, maleimide, sulphonyl halide, phosphoramidite, acid halide, alkylimidate, hydrazide and carbodiimide, and L is selected from the group consisting of a straight or branched C 1-20 alkyl chain a C 2-20 monoether or polyether and a C 2-20 atom chain containing to four secondary amide linkages;

wherein,

at least one of groups R 2 to R 9 is a functional group selected from the group consisting of amino, hydroxyl, phosphoryl, carbonyl and sulphydryl; or wherein at least one of groups R 2 to R 9 is a reactive group selected from succinimidyl ester, isothiocyanate, anhydride, haloacetamide, maleimide, sulphonyl halide, phosphoramidite, acid halide, alkylimidate, hydrazide and carbodiimide that can covalently bond with said at least one functional group, or at least one of the groups R 2 to R 9 is hydrogen, methyl, phenyl or naphthyl;

R 1 is selected from hydrogen, aryl, heteroaryl, cyano, nitro, aldehyde, halogen, hydroxy, amino, quaternary amino, acetal, ketal, phosphoryl, sulphydryl, and alkyl groups optionally substituted by amino, C 1 -C 4 alkyl-substituted amino, quaternary amino, aldehyde, ketone, acetal, ketal, halo, cyano, aryl, heteroaryl, hydroxyl, sulphonate, sulphate, carboxylate, amide and nitro;

A is selected from O, S and NR 11 where R 11 is the substituted amino radical:

where R′ is selected from hydrogen, a C 1-4 alkyl and aryl and R″ is selected from C 1-18 alkyl, aryl, heteroaryl, an acyl radical having from 2-7 carbon atoms, and a thiocarbamoyl radical;

X and Y may be the same or different and are selected from bis-C 1 -C 4 alkyl and C 4 -C 5 spiro alkyl substituted carbon, oxygen, sulphur, selenium, and N—W wherein N is nitrogen and W is selected from hydrogen, a group —(CH 2 ) n R 12 where n is an integer from 1 to 26 and R 12 is selected from hydrogen, amino, aldehyde, acetal, ketal, halo, cyano, aryl, heteroaryl, hydroxyl, sulphonate, sulphate, carboxylate, substituted amino, quaternary amino, nitro, primary amide and substituted amide;

Z a and Z b each represent the atoms necessary to complete one, or two fused aromatic rings each ring having six carbon atoms;

provided that

when X and Y are other than carbon, at least one of R 2 -R 9 represents -L-R 10 or R 10 wherein R 10 is said reactive group and L is selected from the group consisting of a straight or branched C 1-20 alkyl chain, a C 2-20 monoether or polyether and a C 2-20 atom chain containing up to four secondary amide linkages, or

when X and Y are different and are selected from O and Se, at least one of R 1 -R 9 is other than hydrogen, methyl, phenyl or naphthyl.

9. A target material selected from antibody, lipid, protein, peptide, carbohydrate, nucleotides which contain or are derivatized to contain one or more of an amino, sulphydryl, carbonyl, hydroxyl and carboxyl, phosphate and thiophosphate groups, and oxy or deoxy polynucleic acids which contain or are derivatized to contain one or more of an amino, sulphydryl, carbonyl, hydroxyl and carboxyl, phosphate and thiophosphate groups, microbial materials, drugs, toxins, particles, plastics or glass surfaces and polymers herein said target material is covalently labelled with a compound (I) of formula:

substituted by groups R 2 -R 9 , wherein groups R 6 , R 7 , R 8 and R 9 are attached to the atoms of the Z a and Z b ring structures;

wherein,

R 2 to R 9 are the same or different and are —R 10 or -L-R 10 where the reactive group R 10 is selected from hydrogen, halogen, amide, C 1 -C 6 alkoxy, nitro, cyano, aryl, heteroaryl, sulphonate, quaternary ammonium, guanidinium, hydroxyl, phosphate, phosphonate, optionally substituted amino, azido, sulphydryl, carboxyl, carbonyl and reactive groups selected from succinimidyl ester, isothiocyanate, anhydride, haloacetamide, maleimide, sulphonyl halide, phosphoramidite, acid halide, alkylimidate, hydrazide and carbodiimide, and L is selected from the group consisting of a straight or branched C 1-20 alkyl chain, a C 2-20 monoether or polyether and a C 2-20 atom chain containing up to four secondary amide linkages;

R 1 is selected from hydrogen, aryl, heteroaryl, cyano, nitro, aldehyde, halogen, hydroxy, amino, quaternary amino, acetal, ketal, phosphoryl, sulphydryl, and alkyl groups optionally substituted by amino, C 1 -C 4 alkyl-substituted amino, quaternary amino, aldehyde, ketone, acetal, ketal, halo, cyano, aryl, heteroaryl, hydroxyl, sulphonate, sulphate, carboxylate, amide and nitro;

A is selected from O, S and NR 11 where R 11 is the substituted amino radical:

where R′ is selected from hydrogen, a C 1-4 alkyl and aryl and R″ is selected from C 1-18 alkyl, aryl, heteroaryl, an acyl radical having from 2-7 carbon atoms, and a thiocarbamoyl radical;

X and Y may be the same or different and are selected from bis-C 1 -C 4 alkyl and C 4 -C 5 spiro alkyl substituted carbon, oxygen, sulphur, selenium, and N—W wherein N is nitrogen and W is selected from hydrogen, a group —(CH 2 ) n R 12 where n is an integer from 1 to 26 and R 12 is selected from hydrogen, amino, aldehyde, acetal, ketal, halo, cyano, aryl, heteroaryl, hydroxyl, sulphonate, sulphate, carboxylate, substituted amino, quaternary amino, nitro, primary amide and substituted amide;

Z a and Z b each represent the atoms necessary to complete one, or two fused aromatic rings each ring having six carbon atoms;

provided that

when X and Y are different and are selected from O and Se, at least one of R 1 -R 9 is other than hydrogen, methyl, phenyl or naphthyl.

10. The target material of claim 8 wherein R 1 is selected from hydrogen, aryl, heteroaryl, cyano, halogen, alkyl groups of twenty-six carbon atoms or less and —(CH 2 ) n Q where 1<n<26 and Q is selected from amino, aldehyde, hydroxyl and groups reactive with amino, hydroxyl, aldehyde, phosphoryl, or sulphydryl groups and R 2 , R 3 , R 4 and R 5 are hydrogen.

11. The target material of claim 8 wherein compound (I) is selected from:

i) 6,7,9,10-Tetrahydro-2,14-carboxymethyl-16,16,18,18-tetramethyl-7aH, 8aH-bisindolinium[3,2-a;3′2′-a′]pyrano[3,2-c;5,6-c′]dipyridin-5-ium (Compound I);

ii) 8,9,11,12-Tetrahydro-3,17-disulphonato-20,20,22,22-tetramethyl-9aH,10aH-bisbenz[e]indolinium[3,2-a,3′2′-a]pyrano[3,2-c;5,6-c′]dipyridin-7-ium (Compound II);

iii) 6,7,9,10-Tetrahydro-2-carboxymethyl-14-sulphonato-16,16,18,18-tetramethyl-7aH,8aH-bisindolinium[3,2-a,3′2′-a]pyrano[3,2-c;5,6-c′]dipyridin-5-ium (Compound III);

iv) 6,7,9,10-Tetrahydro-2-carboxymethyl-14-sulphonato-16,16,18,18-tetramethyl-7aH,8aH-bisindolinium[3,2-a,3′2′-a]pyrano[3,2-c;5,6-c′]dipyridin-5-ium, glycinamide (Compound IV);

v) 6,7,9,10-Tetrahydro-2-carboxymethyl-14-sulphonato-16,16,18,18-tetramethyl-7aH,8aH-bisindolinium[3,2-a,3′2′-a]pyrano[3,2-c;5,6-c′]dipyridin-5-ium, N-(2-aminoethylcarboxamide) (Compound V);

vi) 6,7,9,10-Tetrahydro-2-(N-formyl)aminomethyl-14-sulphonato-16,16,18,18-tetramethyl-7aH,8aH-bisindolinium[3,2-a,3′2′-a]pyrano[3,2-c;5,6-c′]dipyridin-5-ium (Compound VI);

vii) 6,7,9,10-Tetrahydro-2-hydroxyethyl-16,16,18,18-tetramethyl-7aH,8aH-bisindolinium[3,2-a,3′2′-a]pyrano[3,2-c;5,6-c′]dipyridin-5-ium (Compound VII);

viii) 6,7,8,10-Tetrahydro-14-carboxymethyl-16,16-dimethyl-7a-8a-benzothiazolenine-indolenine-[3,2-a]-benzthiazolyl[3′2′-a]-pyrano[3,2-c;5,6-c′]dipyridin-5-ium (Compound VIII);

ix) 6,7,8,8a,9,10-Hexahydro-2,14-disulphonato-8-(4-carboxy-anilino)-16,16,18,18-tetramethyl-7aH-bis-indolinium[3,2-a;3′2′-a′]pyrido[3,2-c;5,6-c′]dipyridin-5-ium (Compound IX);

x) 6,7,9,10-Tetrahydro-14-carboxymethyl-16,16-dimethyl-7a-8a-quinolino-indolenium-[3,2-a,3′2′-a]-pyrano[3,2-c;5,6-c′]dipyridin-5-ium (Compound X).

12. The target material of claim 8 wherein the compound (I) is 6,7,9,10-Tetrahydro-2-carboxymethyl-14-sulphonato-16,16,18,18-tetramethyl-7aH,8aH-bisindolinium[3,2-a,3′2′-a]pyrano[3,2-c;5,6-c′]dipyridin-5-ium or its esters.

13. The target material of claim 12 wherein the ester is a N-hydroxysuccinimidyl ester.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jan 30, 2024
From: CARNEGIE-MELON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 066381/0883 →
Continuity (6)
Division 10351369 · Jan 27, 2003
Continuation 09639941 · Aug 17, 2000
Continuation 09212564 · Dec 16, 1998
Continuation PCTUS9826665 · Dec 16, 1998
Continuation In Part 08992212 · Dec 17, 1997
Related Publication 20090281279A1 · Nov 12, 2009